A detailed history of Geode Capital Management, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 935,568 shares of IPSC stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
935,568
Previous 510,591 83.23%
Holding current value
$1.5 Million
Previous $2.13 Million 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.46 - $4.05 $1.05 Million - $1.72 Million
424,977 Added 83.23%
935,568 $2.39 Million
Q1 2024

May 13, 2024

BUY
$3.19 - $5.32 $134,407 - $224,152
42,134 Added 8.99%
510,591 $2.13 Million
Q4 2023

Feb 13, 2024

BUY
$1.28 - $3.32 $4,825 - $12,516
3,770 Added 0.81%
468,457 $1.56 Million
Q3 2023

Nov 13, 2023

BUY
$2.0 - $3.23 $42,376 - $68,437
21,188 Added 4.78%
464,687 $929,000
Q2 2023

Aug 11, 2023

BUY
$2.91 - $3.53 $64,957 - $78,796
22,322 Added 5.3%
443,499 $1.4 Million
Q1 2023

May 15, 2023

BUY
$3.4 - $5.11 $38,923 - $58,499
11,448 Added 2.79%
421,177 $1.46 Million
Q4 2022

Feb 13, 2023

BUY
$4.84 - $11.58 $124,542 - $297,976
25,732 Added 6.7%
409,729 $2.1 Million
Q3 2022

Nov 14, 2022

BUY
$8.57 - $13.1 $863,041 - $1.32 Million
100,705 Added 35.55%
383,997 $3.8 Million
Q2 2022

Aug 12, 2022

BUY
$7.96 - $12.43 $122,480 - $191,260
15,387 Added 5.74%
283,292 $2.38 Million
Q1 2022

May 13, 2022

BUY
$11.62 - $15.92 $610,991 - $837,089
52,581 Added 24.42%
267,905 $3.37 Million
Q4 2021

Feb 11, 2022

BUY
$13.93 - $23.62 $148,117 - $251,151
10,633 Added 5.19%
215,324 $3.42 Million
Q3 2021

Nov 12, 2021

BUY
$20.8 - $31.93 $3.45 Million - $5.3 Million
166,023 Added 429.36%
204,691 $5.15 Million
Q2 2021

Aug 13, 2021

BUY
$22.45 - $29.34 $868,096 - $1.13 Million
38,668 New
38,668 $1.13 Million

Others Institutions Holding IPSC

About Century Therapeutics, Inc.


  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $94.2M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.